Open AccessP848: TINOSTAMUSTINE (EDO‐S101), AN ALKYLATOR AND HISTONE DEACETYLASE INHIBITOR, ENHANCES THE EFFICACY OF DARATUMUMAB IN PRECLINICAL MODELS OF MULTIPLE MYELOMA
Author(s) -
DiazTejedor A.,
SanSegundo L.,
Corchete L. A.,
GonzálezMéndez L.,
MartínSánchez M.,
LorenzoMohamed M.,
GonzálezRodríguez M.,
CruzHernández M.,
SánchezBlázquez M.,
Gutiérrez N. C.,
Mateos M.V.,
Garayoa M.,
Ocio E. M.,
Paíno T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846276.07813.d5
Subject(s) - daratumumab , cd38 , bortezomib , cancer research , in vivo , flow cytometry , ex vivo , bone marrow , cell culture , microbiology and biotechnology , chemistry , histone deacetylase inhibitor , multiple myeloma , histone deacetylase , in vitro , medicine , immunology , biology , histone , dna , biochemistry , stem cell , cd34 , genetics